BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 19081481)

  • 1. Biological behavior and prognosis of familial papillary thyroid carcinoma.
    Ito Y; Kakudo K; Hirokawa M; Fukushima M; Yabuta T; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
    Surgery; 2009 Jan; 145(1):100-5. PubMed ID: 19081481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
    Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F
    Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.
    Lee YM; Yoon JH; Yi O; Sung TY; Chung KW; Kim WB; Hong SJ
    J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
    Alsanea O; Wada N; Ain K; Wong M; Taylor K; Ituarte PH; Treseler PA; Weier HU; Freimer N; Siperstein AE; Duh QY; Takami H; Clark OH
    Surgery; 2000 Dec; 128(6):1043-50;discussion 1050-1. PubMed ID: 11114641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial non-medullary thyroid cancer: a matched-case control study.
    Maxwell EL; Hall FT; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of tumour size in papillary and follicular thyroid cancer.
    Passler C; Scheuba C; Asari R; Kaczirek K; Kaserer K; Niederle B
    Br J Surg; 2005 Feb; 92(2):184-9. PubMed ID: 15685703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
    Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
    Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway.
    Frich L; Glattre E; Akslen LA
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):113-7. PubMed ID: 11219767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial papillary carcinoma of the thyroid: report of three families.
    Ríos A; Rodríguez JM; Illana J; Torregrosa NM; Parrilla P
    Eur J Surg; 2001 May; 167(5):339-43. PubMed ID: 11419547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial papillary carcinoma of the thyroid: a report of nine first-degree relatives of four families.
    Marchesi M; Biffoni M; Biancari F; Faloci C; Cresti R; Mariotti F; Nobili Benedetti R; Campana FP
    Eur J Surg Oncol; 2000 Dec; 26(8):789-91. PubMed ID: 11087647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
    Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Total thyroidectomy of choice in papillary microcarcinoma].
    Pisello F; Geraci G; Sciumè C; Li Volsi F; Modica G
    G Chir; 2007; 28(1-2):13-9. PubMed ID: 17313727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central compartment dissection in thyroid papillary carcinoma.
    Forest VI; Clark JR; Ebrahimi A; Cho EA; Sneddon L; Gao K; O'brien CJ
    Ann Surg; 2011 Jan; 253(1):123-30. PubMed ID: 21135696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial papillary thyroid carcinoma].
    Ji Q; Wu Y; Zhu Y; Wang Y; Zhang R; Luo Z
    Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):564-6. PubMed ID: 12417064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation.
    Ng SB; Sittampalam K; Goh YH; Eu KW
    Pathology; 2003 Feb; 35(1):42-6. PubMed ID: 12701683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial nonmedullary thyroid cancer].
    Sugino K; Mimura T; Ito K; Ito K
    Nihon Rinsho; 2000 Jul; 58(7):1519-22. PubMed ID: 10921335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.
    Cao J; Chen C; Chen C; Wang QL; Ge MH
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):598-606. PubMed ID: 26191611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
    Moses W; Weng J; Kebebew E
    Thyroid; 2011 Apr; 21(4):367-71. PubMed ID: 21190444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.